OLIGOMETASTATIC CLEAR CELL RENAL CELL CARCINOMA
Clinical trials for OLIGOMETASTATIC CLEAR CELL RENAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new OLIGOMETASTATIC CLEAR CELL RENAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for OLIGOMETASTATIC CLEAR CELL RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a triple strike of radiation, targeted therapy, and immunotherapy tame metastatic kidney cancer?
Disease control Recruiting nowThis phase II trial is testing whether combining precise, high-dose radiation (SABR) with the targeted drug axitinib and the immunotherapy toripalimab can shrink or control tumors in people with oligometastatic clear cell renal cell carcinoma—kidney cancer that has spread to five…
Matched conditions: OLIGOMETASTATIC CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Hebei Medical University Fourth Hospital • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
New hope for kidney cancer: drug combo after radiation shows promise in early trial
Disease control Recruiting nowThis study tests two immunotherapy drugs, cemiplimab and fianlimab, given after targeted radiation for kidney cancer that has spread to a few spots in the body. The goal is to see if adding fianlimab helps control the cancer longer than cemiplimab alone. About 72 adults with clea…
Matched conditions: OLIGOMETASTATIC CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: University of Oklahoma • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC